Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Items 101–200 of 964
Marijon, É., Garcia, R., Narayanan, K., Karam, N., & Jouven, X. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab903 · Cited by 75
Raatikainen, M. J. P., Arnar, D. O., Zeppenfeld, K., Merino, J. L., Kück, K., & Hindricks, G. (2015) · EP Europace · doi:10.1093/europace/euv265 · Cited by 73
Dinov, B., Arya, A., Schratter, A., Schirripa, V., Fiedler, L., Sommer, P., Bollmann, A., Rolf, S., Piorkowski, C., & Hindricks, G. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002295 · Cited by 70
“Peripheral vascular disease, n (%) 3 (3)”
Maury, P., Baratto, F., Zeppenfeld, K., Klein, G. J., Delacrétaz, E., Sacher, F., Pruvot, E. J., Brigadeau, F., Rollin, A., Andronache, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu040 · Cited by 70
Distribution of late potentials within infarct scars assessed by ultra high-density mapping
Nakahara, S., Tung, R. H., Ramírez, R. J., Gima, J., Wiener, I., Mahajan, A., Boyle, N. G., & Shivkumar, K. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.07.032 · Cited by 69
Sivagangabalan, G., Barry, M. A., Huang, K., Lu, J., Pouliopoulos, J., Thomas, S. P., Ross, D. L., Thiagalingam, A., & Kovoor, P. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02602.x · Cited by 68
Electrical storm: definitions, clinical importance, and treatment
Gao, D., & Sapp, J. L. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835b59db · Cited by 78
“The Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial [50] enrolled 128 patients with ventricular tachycardia who were not treated with antiarrhythmic drugs.”
Mishkin, J. D., Saxonhouse, S. J., Woo, G. W., Burkart, T. A., Miles, W. M., CONTI, J. B., Schofield, R. S., Sears, S. F., & Aranda, J. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.039 · Cited by 71
Bunch, T. J., Weiss, J. P., Crandall, B. G., DAY, J. D., Dimarco, J., Ferguson, J., Mason, P. K., McDaniel, G. M., Osborn, J. S., Wiggins, D., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01680.x · Cited by 67
Martinez, B. K., Baker, W. L., Konopka, A., Giannelli, D., Coleman, C. I., Kluger, J., & Cronin, E. M. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.04.024 · Cited by 73
Examining the safety of amiodarone
Santangeli, P., Biase, L. D., BURKHARDT, J. D., Bai, R., Mohanty, P. K., Pump, A., & Natale, A. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.660915 · Cited by 65
“To this regard, non-pharmacological therapies such as substrate-based radiofrequency catheter ablation might represent suitable alternatives to antiarrhythmic drug therapy, since they have been consistently demonstrated effective in reducing the recurrence of ventricular arrhythmias in patients with ischemic cardiomyo…”
BackgroundReal-Time Localization of Ventricular Tachycardia Origin From the 12-Lead Electrocardiogram
Sapp, J. L., Bar‐Tal, M., Howes, A. J., Toma, J., El‐Damaty, A., Warren, J. W., MacInnis, P. J., Zhou, S., & Horáček, B. M. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.02.024 · Cited by 63
Improving MR Image Quality in Patients with Metallic Implants
Lee, E., Ibrahim, E.-S. H., Dudek, N., Lu, J. C., Kalia, V., Runge, M., Srinivasan, A., Stojanovska, J., & Agarwal, P. P. (2021) · Radiographics · doi:10.1148/rg.2021200092 · Cited by 62
Safety of Ventricular Tachycardia Ablation in Clinical Practice
Katz, D. F., Turakhia, M. P., Sauer, W. H., Tzou, W. S., Heath, R. R., Zipse, M. M., Aleong, R. G., Varosy, P. D., & Kao, D. P. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002336 · Cited by 62
“001 <18 10 (0) 14 (1) 153 (3) 18–29 68 (3) 54 (3) 383 (7) 30–39 138 (7) 96 (5) 511 (9) 40–49 276 (14) 188 (10) 811 (14) 50–59 342 (17) 295 (15) 930 (16) 60–69 442 (22) 367 (19) 954 (17) >70 606 (30) 510 (26) 1086 (19) NA 133 (7) 453 (23) 854 (15) Sex <0.”
InfluentialHemodynamic Support in Ventricular Tachycardia Ablation
Turagam, M. K., Vuddanda, V. L. K., Atkins, D., Santangeli, P., Frankel, D. S., Tung, R. H., Vaseghi, M., Sauer, W. H., Tzou, W. S., Mathuria, N. S., et al. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.07.005 · Cited by 62
Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward
Natale, A., Zeppenfeld, K., Bella, P. E. D., Liu, X., Sabbag, A., Santangeli, P., Sommer, P., Sticherling, C., Zhang, X., & Biase, L. D. (2023) · EP Europace · doi:10.1093/europace/euad225 · Cited by 61
Management of Ventricular Arrhythmias Worldwide
Könemann, H., Ellermann, C., Zeppenfeld, K., & Eckardt, L. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.12.008 · Cited by 79
Waight, M. C., Prakosa, A., Li, A. C., Bunce, N., Marciniak, A., Trayanova, N. A., & SABA, M. M. (2025) · Circulation · doi:10.1161/circulationaha.124.070526 · Cited by 60
Kawamura, I., Reddy, V. Y., Santos‐Gallego, C. G., Wang, B. J., Chaudhry, H. W., Buck, E. D., Mavroudis, G., Jerrell, S., Schneider, C. W., Speltz, M., et al. (2023) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.122.011369 · Cited by 59
Self-citationArya, A., Bode, K., Piorkowski, C., Bollmann, A., Sommer, P., Gaspar, T., Wetzel, U., Husser, D., Kottkamp, H., & Hindricks, G. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02835.x · Cited by 59
El anciano con cardiopatía terminal
Martínez‐Sellés, M., Vidán, M. T., López‐Palop, R., Rexach, L., Sánchez, E., Datino, T., Cornide, M., Carrillo, P., Ribera, J. M., Díaz-Castro, Ó., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70898-x · Cited by 73
Ventricular Tachycardia Ablation in Severe Heart Failure
Tzou, W. S., Tung, R. H., Frankel, D. S., Vaseghi, M., Bunch, T. J., Biase, L. D., Tholakanahalli, V. N., Lakkireddy, D., Dickfeld, T. M., SALIARIS, A. P., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004494 · Cited by 58
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
Iwasaki, Y., Noda, T., Akao, M., Fujino, T., Hirano, T., Inoue, K., KUSANO, K. F., Nagai, T., Satomi, K., Shinohara, T., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-24-0073 · Cited by 77
Outcome of Invasive Electrophysiological Procedures and Gender: Are Males and Females the Same?
Santangeli, P., Biase, L. D., Pelargonio, G., & Natale, A. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01920.x · Cited by 61
Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices
Kusa, S., Miller, M. A., Whang, W., Enomoto, Y., González‐Panizo, J., Iwasawa, J., Choudry, S., Pinney, S., Gomes, A., Langan, N., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004717 · Cited by 57
Self-citationEHRA White Paper: knowledge gaps in arrhythmia management—status 2019
Goette, A., Auricchio, A., Boriani, G., Braunschweig, F., Brugada, J., Burri, H., Camm, A. J., Crijns, H. J. G. M., Dagres, N., Deharo, J., et al. (2019) · EP Europace · doi:10.1093/europace/euz055 · Cited by 61
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2020) · EP Europace · doi:10.1093/europace/euz332 · Cited by 61
Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence
Quinto, L., Sánchez-Somonte, P., Alarcón, F., Garre, P., Castillo, À., Antonio, R. S., Borràs, R., Guasch, E., Arbelo, E., Tolosana, J. M., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.02.016 · Cited by 56
“VT ablation after an initial VT episode has resulted in a significant reduction in ICD shocks and hospitalizations, and one study demonstrated a trend toward improved survival and reduced likelihood of VT storms.(7,8) Initial experience has reported significant VT burden reduction after ablation in patients with nonis…”
BackgroundLü, F., Eckman, P., Liao, K. K., Apostolidou, I., John, R., Chen, T., Das, G. S., Francis, G. S., Lei, H., Trohman, R. G., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.035 · Cited by 55
Abuissa, H. S., Roshan, J., Lim, B., & Asirvatham, S. J. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01673.x · Cited by 55
Deyell, M. W., AbdelWahab, A. M., Angaran, P., Essebag, V., Glover, B., Gula, L. J., Khoo, C., Lane, C. J., Nault, I., Nery, P. B., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.04.004 · Cited by 65
Arenal, Á., Hernández, J., Calvo, D., Ceballos, C., Atéa, L., Datino, T., Atienza, F., González‐Torrecilla, E., Eídelman, G., Miracle, A. L., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.031 · Cited by 54
Intracardiac echocardiography in complex cardiac catheter ablation procedures
Banchs, J. E., Patel, P. P., Naccarelli, G. V., & Gonzalez, M. D. (2010) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-010-9474-8 · Cited by 54
“It has also been shown that ablation for ischemic VT prior to implanting a defibrillator decreases the incidence of defibrillator therapies in patients receiving them for secondary prevention [5].”
BackgroundAntiarrhythmic and Nonantiarrhythmic Drugs for Sudden Cardiac Death Prevention
Das, M. K., & Zipes, D. P. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d64dde · Cited by 57
“Often, catheter ablation of ventricular arrhythmias is the initial therapy and AADs are used only if the arrhythmia recurs.(6) Over the past three decades, multiple risk markers for SCD have been used to design AAD studies in patients with CAD, Received for publication October 26, 2009; accepted January 19, 2010.”
Sudden Cardiac Death in Ischemic Heart Disease
Gräni, C., Benz, D. C., Gupta, S., Windecker, S., & Kwong, R. Y. K. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.10.021 · Cited by 61
Electrical Storm: Incidence, Prognosis and Therapy.
Sagone, A. (2015) · PubMed · doi:10.4022/jafib.1150 · Cited by 55
End Points for Ablation of Scar-Related Ventricular Tachycardia
Santangeli, P., Frankel, D. S., & Marchlinski, F. E. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001585 · Cited by 52
“949 The goal of catheter ablation strategies for the treatment of scar-related ventricular tachycardia (VT) is the interruption of critical areas of slow conduction within the VT circuits responsible for the development and maintenance of VTs.1,2 Clinical studies have consistently shown the superiority of radiofrequen…”
BackgroundInfluentialCardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation
Richardson, T. D., Lugo, R. M., Saavedra, P. J., Crossley, G. H., Clair, W. K., Shen, S. T., Estrada, J. C., Montgomery, J. A., Shoemaker, M. B., Ellis, C. R., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.006 · Cited by 52
Huang, D. T.-C., & Traub, D. M. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.07.003 · Cited by 51
Tzou, W. S., Tung, R. H., Frankel, D. S., Biase, L. D., Santangeli, P., Vaseghi, M., Bunch, T. J., Weiss, J. P., Tholakanahalli, V. N., Lakkireddy, D., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.008 · Cited by 51
Shirai, Y., Liang, J. J., Santangeli, P., Arkles, J., Schaller, R. D., Supple, G. E., Nazarian, S., Garcia, F. C., Lin, D., Dixit, S., et al. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007249 · Cited by 51
Sex and Catheter Ablation for Ventricular Tachycardia
Frankel, D. S., Tung, R. H., Santangeli, P., Tzou, W. S., Vaseghi, M., Biase, L. D., Nagashima, K., Tedrow, U. B., Bunch, T. J., Tholakanahalli, V. N., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2361 · Cited by 50
Tung, R. H., Nakahara, S., Maccabelli, G., Buch, E. F., Wiener, I., Boyle, N. G., Carbucicchio, C., Bella, P. E. D., & Shivkumar, K. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01859.x · Cited by 49
“Acute procedural results were categorized in 3 groups: (1) complete success—noninducible after ablation for all VTs; (2) partial success—inducible for nontargeted VT; and (3) failure— inducible for targeted/clinical VT.”
MethodVentricular Tachycardia Burden and Mortality: Association or Causality?
Samuel, M., Elsokkari, I., & Sapp, J. L. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.01.016 · Cited by 60
Carbucicchio, C., Bella, P. E. D., Fassini, G. M., Trevisi, N. M., Riva, S. I., Giraldi, F., Baratto, F., Marenzi, G., Sisillo, E., Bartorelli, A. L., et al. (2009) · Herz · doi:10.1007/s00059-009-3289-3 · Cited by 48
Misra, S. K., van Dam, P. M., Chrispin, J., Assis, F., Keramati, A. R., Kolandaivelu, A., Berger, R. D., & Tandri, H. S. (2018) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2018.05.018 · Cited by 48
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12185 · Cited by 64
Haqqani, H. M., & Marchlinski, F. E. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.023 · Cited by 47
“Catheter ablation has emerged as an important manageent option for patients with ventricular tachycardia (VT) o reduce or prevent implantable cardioverter-defibrillator hocks.(5,6) Frequently, mapping and ablation of VT must be erformed in sinus rhythm because the majority of clinical r induced VTs are unmappable due…”
BackgroundA New Era in Epicardial Access for the Ablation of Ventricular Arrhythmias
Calvo, J. J. C. J., Bokhari, F., Uuetoa, H., Derejko, P., TRAYKOV, V. B., Gwizdała, A., Sebag, F. A., Hegbom, F., Anfinsen, O., AlQubbany, A., et al. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.07.027 · Cited by 47
End-Stage Heart Disease in the Elderly
Martínez‐Sellés, M., Vidán, M. T., López‐Palop, R., Rexach, L., Sánchez, E., Datino, T., Cornide, M., Carrillo, P., Ribera, J. M., Díaz-Castro, Ó., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71668-8 · Cited by 50
“30 Thus, it could also be an alternative when preventing new episodes of ventricular tachyarrhythmias in some patients, but we should bear in mind that this is an invasive treatment.”
BackgroundEHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J. M., Borggrefe, M., Bella, P. E. D., Dickfeld, T. M., Dorian, P., Huikuri, H. V., Kim, Y. D., Knight, B. P., et al. (2014) · Journal of Arrhythmia · doi:10.1016/j.joa.2014.08.001 · Cited by 44
“Catheter ablation has been demonstrated to reduce appropriate ICD shocks for patients with ischaemic cardiomyopathy when utilized after a first presentation with VA [147].”
BackgroundSafety and Outcomes of Ventricular Tachycardia Substrate Ablation During Sinus Rhythm
Fernández‐Armenta, J., Soto‐Iglesias, D., Silva, E., Penela, D., Jáuregui, B., Linhart, M., Bisbal, F., Acosta, J., Fernández, M., Borràs, R., et al. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.07.028 · Cited by 44
Mechanisms that initiate ventricular tachycardia in the infarcted human heart
Segal, O. R., CHOW, A. W. C., Peters, N. S., & Davies, D. W. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.09.025 · Cited by 44
Liang, J. J., Santangeli, P., & Callans, D. J. (2015) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2015.4.3.177 · Cited by 43
Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort
Yousuf, O. K., Zusterzeel, R., Sanders, W., Caños, D., Dekmezian, C., SILVERMAN, H. J., Calkins, H. G., Berger, R. D., Tandri, H. S., Nazarian, S., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.06.020 · Cited by 44
“58 to 65 years) (11,13–15,21,22) and had a higher prevalence of renal disease, diabetes (21), and hypertension (21,23).”
BackgroundRanjan, R., McGann, C. J., Jeong, E.-K., Hong, K., Kholmovski, E. G., Blauer, J. J. E., Wilson, B. D., Marrouche, N. F., & Kim, D. C. (2014) · EP Europace · doi:10.1093/europace/euu263 · Cited by 43
“Consequently, not ablating these substrates could lead to future VT events.(6,7) Late gadolinium enhanced (LGE)(8) magnetic resonance imaging”
BackgroundGold, M. R. (2010) · Yearbook of Cardiology · doi:10.1016/s0145-4145(10)79891-9 · Cited by 43
Better Lesion Creation And Assessment During Catheter Ablation.
Kumar, S., Barbhaiya, C. R., Balindger, S., John, R. M., Epstein, L. M., Koplan, B. A., Tedrow, U. B., Stevenson, W. G., & Michaud, G. F. (2015) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1189 · Cited by 47
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.004 · Cited by 44
Catheter ablation for paroxysmal and persistent atrial fibrillation
Chen, H. S., Wen, J., Wu, S., & Liu, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007101.pub2 · Cited by 43
Survival After Implantable Cardioverter-Defibrillator Shocks
Aktaş, M. K., Younis, A., Zaręba, W., Kutyifa, V., Klein, H., Daubert, J. P., Estes, M., McNitt, S. A., Polonsky, B., & Goldenberg, I. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.329 · Cited by 42
Inada, K., Roberts‐Thomson, K. C., Seiler, J., Steven, D., Tedrow, U. B., Koplan, B. A., & Stevenson, W. G. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.02.019 · Cited by 41
Bunch, T. J., Weiss, J. P., Crandall, B. G., Day, J. D., May, H. T., Bair, T. L., Osborn, J. S., Mallender, C. D., Fischer, A., Brunner, K. J., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.12.014 · Cited by 42
Lakkireddy, D., Shenthar, J., Garg, J., Padmanabhan, D., Gopinathannair, R., Biase, L. D., Romero, J. E., Mohanty, S., BURKHARDT, D. J., Al‐Ahmad, A., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.07.010 · Cited by 41
Nagashima, K., Watanabe, I., Okumura, Y., Ohkubo, K., Kofune, M., Ohya, T., Kasamaki, Y., & Hirayama, A. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0870 · Cited by 41
de Lepper, A. G. W., Buck, C. M. A., Veer, M. V. ’., Huberts, W., van de Vosse, F. N., & Dekker, L. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0317 · Cited by 43
Defibrillators: Selecting the Right Device for the Right Patient
Al‐Khatib, S. M., Friedman, P. A., & Ellenbogen, K. A. (2016) · Circulation · doi:10.1161/circulationaha.116.021889 · Cited by 47
Reassessing Noninducibility as Ablation Endpoint of Post-Infarction Ventricular Tachycardia
Riva, M., Piers, S. R. D., Kapel, G. F. L., Watanabe, M., Venlet, J., Trines, S. A. I. P., Schalij, M. J., & Zeppenfeld, K. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002702 · Cited by 39
Ravi, V., Poudyal, A., Khanal, S., Khalil, C., Vij, A., Sanders, D. J., Larsen, T. R., Trohman, R. G., Aksu, T., Tung, R. H., et al. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01287-w · Cited by 40
“(SURVIVE VT), only sinus rhythm mapping and substrate modification were performed [5, 10].”
BackgroundMethodResultInfluentialRole of antiarrhythmic drugs in patients with implantable cardioverter defibrillators
Herendael, H. V., Pintér, A., Ahmad, K., Korley, V. J., Mangat, I., & Dorian, P. (2010) · EP Europace · doi:10.1093/europace/euq073 · Cited by 41
Duray, G. Z., Schmitt, J., Richter, S., Israel, C. W., & Hohnloser, S. H. (2009) · EP Europace · doi:10.1093/europace/eup246 · Cited by 44
Kheiri, B., Barbarawi, M., Zayed, Y., Hicks, M., Osman, M., Rashdan, L., Kyi, H. H., Bachuwa, G. I., Hassan, M., Stecker, E. C., et al. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007600 · Cited by 39
The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients
Li, A. C., Kaura, A., Sunderland, N. P., Dhillon, P. S., & Scott, P. A. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016.12.2 · Cited by 41
“003); however, mortality did not differ between the groups.(48)”
Graham, A. J., Orini, M., & Lambiase, P. D. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2017.20.1 · Cited by 36
“The randomised, primary-prevention trial, SMASH VT, showed a reduction in VT events using a substrate-based approach.(35) The positive results of this trial, which achieved a 70 % reduction in arrhythmic events at 2 years, has not been replicated.”
MethodMagnetic resonance imaging guidance for the optimization of ventricular tachycardia ablation
Mukherjee, R. K., Whitaker, J., Williams, S. E., Razavi, R., & O'Neill, M. D. (2018) · EP Europace · doi:10.1093/europace/euy040 · Cited by 39
Catheter Ablation of Ventricular Tachycardia
Tung, R. H., Boyle, N. G., & Shivkumar, K. (2011) · Circulation · doi:10.1161/circulationaha.110.989079 · Cited by 36
Soto‐Iglesias, D., Acosta, J., Penela, D., Fernández‐Armenta, J., Cabrera, M., Martínez, M., Vassanelli, F., Alcaine, A., Linhart, M., Jáuregui, B., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.02.007 · Cited by 36
Peichl, P., Wichterle, D., Cihak, R. J., Aldhoon, B., & Kautzner, J. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12844 · Cited by 35
Trayanova, N. A., Doshi, A. N., & Prakosa, A. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1477 · Cited by 35
“…discussed (Prakosa et al., 2018), since early use of VT ablation post-infarction has been shown to result in much improved patient outcomes (Reddy et al., 2007; Tung, Josephson, Reddy, Reynolds, & SMASH-VT Investigators, 2010), an accurate and easily executed VT ablation will lead to…”
BackgroundDawkins, J. F., Ehdaie, A., Rogers, R. G., Soetkamp, D., Valle, J., Holm, K., Sanchez, L., Tremmel, I., Nawaz, A., Shehata, M. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac042 · Cited by 36
Gasparini, M., Lunati, M., Landolina, M., Santini, M., Padeletti, L., Perego, G. B., Vincenti, A., Curnis, A., Carboni, A., Denaro, A., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.035 · Cited by 35
Managing with pacemakers and implantable cardioverter defibrillators
Lampert, R. (2013) · Circulation · doi:10.1161/circulationaha.113.001555 · Cited by 34
Carbucicchio, C., Raja, N., Biase, L. D., Volpe, V., Russo, A. D., Trivedi, C. G., Bartoletti, S., Zucchetti, M., Casella, M., Russo, E., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.09.059 · Cited by 34
Treatment of ventricular arrhythmias: What's New?
Markman, T. M., & Nazarian, S. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.09.014 · Cited by 34
Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia
Kosmidou, I., Inada, K., Seiler, J., Koplan, B. A., Stevenson, W. G., & Tedrow, U. B. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.06.021 · Cited by 33
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
Muratore, C. A. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s8355 · Cited by 33
“We speculate that as it happens in patients with ischemic VT, RF ablation in addition to an ICD may reduce the incidence of therapies delivered by the device.(55)”
New drugs vs. old concepts: A fresh look at antiarrhythmics
Thireau, J., Pasquié, J., Martel, E., Guennec, J. L., & Richard, S. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.003 · Cited by 35
“These are AA drugs and the implantation of ICD, eventually combined with surgical or percutaneous catheter ablation (Reddy et al., 2007).”
BackgroundClinical Management of Ventricular Tachycardia
Pellegrini, C. N., & Scheinman, M. M. (2010) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2010.08.001 · Cited by 37
SABA, M. M., Akella, J., Gammie, J. S., Poston, R. S., Johnson, A., HOOD, R. E., Dickfeld, T.-M., & Shorofsky, S. R. (2009) · EP Europace · doi:10.1093/europace/eup156 · Cited by 33
“As more patients survive longer with the advent of the implantable cardioverter-defibrillator, ablative therapy for ventricular tachycardia (VT) is assuming a more central role in the management of such patients.(1) Substrate-guided approaches to VT ablation have evolved, particularly when dealing with haemodynamicall…”
BackgroundCurrent treatment of ventricular arrhythmias: State of the art
Stevenson, W. G. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.019 · Cited by 39
Tilz, R. R., Lenarczyk, R., Scherr, D., Haugaa, K. H., Iliodromitis, K. E., Pürerfellner, H., Kiliszek, M., & Dagres, N. (2017) · EP Europace · doi:10.1093/europace/eux332 · Cited by 33
Ventricular Tachycardia in the Era of Ventricular Assist Devices
Cesario, D. A., Saxon, L. A., Cao, M. K., Bowdish, M. E., & Cunningham, M. J. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01911.x · Cited by 33
Update on prevention and treatment of sudden cardiac arrest
Krokhaleva, Y., & Vaseghi, M. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.11.002 · Cited by 33
“007) and ICD shocks (9% versus 31%, respectively) in the ablation group compared to ICD only group.(21) Results of the Ventricular Tachycardia Ablation in Coronary Heart Disease (VTACH) trial demonstrated a statistically significant 39% decrease in the rate of ICD shocks at 2 years in the VT ablation group as compared…”
BackgroundMethodResultOuyang, Z., Schoenhagen, P., Wazni, O. M., TCHOU, P. J., Saliba, W. I., Suh, J. H., & Xia, P. (2020) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.13002 · Cited by 32
Ventricular Tachycardia in Ischemic Heart Disease
Lo, R., Chia, K. K. M., & Hsia, H. H. (2017) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2016.10.013 · Cited by 34
Anderson, R. D., Ariyarathna, N., Lee, G., Virk, S. A., Trivic, I., Campbell, T. G., Chow, C. K., Kalman, J. M., & Kumar, S. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.05.026 · Cited by 32
Nelson, T., Garg, P., Clayton, R. H., & Lee, J. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.5.1 · Cited by 34
“VT ablation therefore often targets the myocardial scar substrate.(76) Differing approaches to substrate ablation have been described – linear transection, core isolation, scar homogenisation or abolition of late Table 2: Cont.”
BackgroundElectrical storm: Incidence, Prognosis and Therapy.
Proietti, R., & Sagone, A. (2011) · PubMed Central · Cited by 42
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: A systemic review
Ha, A. H., Ham, I., Nair, G. M., Connolly, S. J., Dorian, P., Morillo, C. A., & Healey, J. S. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.08.032 · Cited by 32
Stereotactic Arrhythmia Radioablation (STAR) of Ventricular Tachycardia: A Treatment Planning Study
Wang, L., Fahimian, B., Soltys, S. G., Zei, P. C., Lo, A., Gardner, E. A., Maguire, P. J., & Loo, B. W. (2016) · Cureus · doi:10.7759/cureus.694 · Cited by 31
“Current available options for limiting the incidence of VT and VA include implantable cardioverterdefibrillators (ICDs) [2-4], antiarrhythmic medications [5-6], and catheter ablation [7].”
Background
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.